Synapse

← RSC Pharmaceutics

Papers in RSC Pharmaceutics

Page 2 · newest first

  1. Sequential- vs . density gradient-centrifugation for the isolation of mitochondria-containing extracellular vesiclesRSC Pharmaceutics · 2026
  2. Ion-triggered nasal formulation to improve brain resilience against neurodegenerative disordersRSC Pharmaceutics · 2026
  3. Microneedles as an effective and minimally invasive delivery strategy for oral cancer treatmentRSC Pharmaceutics · 2026
  4. Microneedle-based delivery of PEGylated nanoparticles triggers the production of anti-PEG antibodiesRSC Pharmaceutics · 2026
  5. Ball milling formation of the metformin–pioglitazone eutectic form by ex situ monitoring: mechanochemical preparation, solid-state characterization, and dissolution profiles determinationRSC Pharmaceutics · 2026
  6. Co-formulation of IL-12 mRNA and doxorubicin in polymeric nanoparticles for simultaneous delivery in murine melanomaRSC Pharmaceutics · 2026
  7. Development, characterization and preclinical evaluation of a formononetin derivative phospholipid complex for improved anticancer activityRSC Pharmaceutics · 2026
  8. Naringenin-encapsulated nano-cochleate hydrogel for topical delivery: cellular anti-inflammatory activity and dermatokinetic profilingRSC Pharmaceutics · 2026
  9. Mast cell agonism for glioblastoma immunotherapyRSC Pharmaceutics · 2026
  10. PLGA and Eudragit-based long-acting microspheres for Parkinson's disease managementRSC Pharmaceutics · 2026
  11. 3D-printed hydrogel-forming microneedles for intradermal donepezil delivery in Alzheimer's diseaseRSC Pharmaceutics · 2026
  12. Nanophotobody-mediated EGFR targeting using lignin nanoassemblies enhances photodynamic efficacy in breast cancerRSC Pharmaceutics · 2026
  13. Formulation of an ultra-high concentration aqueous antibody particle suspensionRSC Pharmaceutics · 2026
  14. Nose-to-brain delivery of IRX4204 by cell-adhesion peptide-functionalized gemini surfactant-phospholipid nanoparticlesRSC Pharmaceutics · 2026
  15. Ultrasound-triggered release of an active Wnt signalling agent (6-bromoindirubin-3-oxime) from perfluorocarbon nanodropletsRSC Pharmaceutics · 2026
  16. Nano-radiosensitisers and chronoradiotherapy: emerging strategies for precision cancer treatmentRSC Pharmaceutics · 2026
  17. Optimization of the RiboGreen assay for total RNA quantification in lipid nanoparticles using a design of experiments approach: exploring saponin as an alternative to conventional surfactantsRSC Pharmaceutics · 2026
  18. Re-modelling of drug–carrier molecular interaction for polymer- and lipid-based nanocarriers using K-nearest neighbors machine learningRSC Pharmaceutics · 2026
  19. Engineering geniposide-loaded solid lipid nanoparticles for sustained release and induced apoptosis in human lung cancer cellsRSC Pharmaceutics · 2026
  20. Dynamic vapor sorption for quality assessment of pharmaceutical coatings: a case study in enteric protectionRSC Pharmaceutics · 2026
  21. Trafficking self-assembling small molecules to mitochondria for ferroptosis-mediated cancer cell deathRSC Pharmaceutics · 2026
  22. Formulation and characterization of a levosulpiride–cannabidiol cyclodextrin–phospholipid inclusion complexRSC Pharmaceutics · 2026
  23. Self-assembly of cationic lipid and its effects on polymeric and biocompatible nanoparticles obtained by emulsion polymerizationRSC Pharmaceutics · 2026
  24. Dissolving microneedle-mediated co-delivery of triamcinolone acetonide and PLGA-encapsulated 5-fluorouracil for improving temporal alignment in keloid therapyRSC Pharmaceutics · 2026
  25. Effects of microparticle composition on colony morphology and viability of encapsulated therapeutic yeast for oral deliveryRSC Pharmaceutics · 2025
  26. High-precision deposition and controlled release of high molecular weight hyaluronic acid from contact lens surfaces using nanoelectrosprayRSC Pharmaceutics · 2025
  27. Enhancing the bioavailability of sparingly-soluble drugs by expandable, solid-solution fibrous dosage formsRSC Pharmaceutics · 2025
  28. Polymersomal delivery enhances third-generation photodynamic therapy with the first white-light-activated peptide photosensitiser for melanomaRSC Pharmaceutics · 2025
  29. Engineering tunable GTP/TPi-responsive liposomes through liposomal membrane modulation using a bis-triphenylphosphonium lipid switchRSC Pharmaceutics · 2025
  30. Formulation and Evaluation of Isosorbide Dinitrate-Loaded Flash-Release Dispersible Sublingual WafersRSC Pharmaceutics · 2025
  31. Controlled Release of Ketoprofen via PLGA Nanoparticles: An In Vitro Study for Rheumatoid Arthritis TherapyRSC Pharmaceutics · 2025
  32. QbD-driven solid dispersion development for enhanced solubility and dissolution of the BCS Class II drug voriconazole as a model drugRSC Pharmaceutics · 2025
  33. Alditols in complex with boronophenylalanine for improving aqueous solubility for boron neutron capture therapyRSC Pharmaceutics · 2025
  34. Formulation and evaluation of a Tridax procumbens -loaded phospholipid complex (phytosome) gel for wound healing and antimicrobial activitiesRSC Pharmaceutics · 2025
  35. Improved localized mRNA delivery using lipid nanoparticles with a novel synthetic cholesterol derivativeRSC Pharmaceutics · 2025
  36. Systematic development and optimization of a microfluidic formulation protocol for liposomal azithromycinRSC Pharmaceutics · 2025
  37. Spray-dried inhalable nano-embedded microparticles of isoniazid and pyridoxine hydrochloride for pulmonary tuberculosisRSC Pharmaceutics · 2025
  38. Chemotherapeutic loaded dynamic aggregated albumin nanoparticles for lung cancer therapyRSC Pharmaceutics · 2025
  39. Sustained drug delivery of the β-blocker acebutolol hydrochloride via chitosan–bilimbi leaf extract filmsRSC Pharmaceutics · 2025
  40. The effect of guide RNA thermal denaturation on the quality of Cas9 ribonucleoprotein-loaded lipid nanoparticle formulationsRSC Pharmaceutics · 2025
  41. Water mimicry enables the formation of a solid solution of caffeine and theophylline sulphate and a new type of non-stoichiometric hydrateRSC Pharmaceutics · 2025
  42. Implementation-focused evaluation of transmission low-frequency Raman spectroscopy parameters for non-destructive quality control of solid dosage formsRSC Pharmaceutics · 2025
  43. The ideal duo for salt formation: vinpocetine and tosylic acidRSC Pharmaceutics · 2025
  44. mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation frameworkRSC Pharmaceutics · 2025
  45. Berberine-doped liposomes enhance Factor IX mutant mRNA delivery for protein replacement therapy in Hemophilia BRSC Pharmaceutics · 2025
  46. Advancements in nano-based drug delivery systems for therapeutics: a comprehensive reviewRSC Pharmaceutics · 2025
  47. An evaluation of the pharmaceutical properties of the Nigerian baobab polysaccharide for sustained release oral tabletsRSC Pharmaceutics · 2025
  48. Development of vismodegib-loaded PLGA nanoparticles for the treatment of pancreatic cancer: Formulation and in vitro assessment in co-culture monolayers and spheroidsRSC Pharmaceutics · 2025
  49. Bio-physical insights into the interaction of biocompatible iron oxide nanoparticles with biomolecules: microcalorimetric and spectroscopic evaluationRSC Pharmaceutics · 2025
  50. Bifunctional sulfur-rich macrocyclic chelators and their immunoconjugates for the targeted delivery of theranostic mercury-197RSC Pharmaceutics · 2025